Aliases & Classifications for Fasciitis

MalaCards integrated aliases for Fasciitis:

Name: Fasciitis 12 54 43 15

Classifications:



External Ids:

Disease Ontology 12 DOID:9598
ICD9CM 34 729.4
MeSH 43 D005208
NCIt 49 C50559
SNOMED-CT 67 36948007
ICD10 32 M72.9
UMLS 71 C0015645

Summaries for Fasciitis

Disease Ontology : 12 A connective tissue disease characterized by inflammation located in the fascia.

MalaCards based summary : Fasciitis is related to ischemic fasciitis and proliferative fasciitis. An important gene associated with Fasciitis is ACTC1 (Actin Alpha Cardiac Muscle 1), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Cimetidine and Imidacloprid have been mentioned in the context of this disorder. Affiliated tissues include fascia, skin and breast, and related phenotypes are cardiovascular system and cellular

Related Diseases for Fasciitis

Diseases related to Fasciitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1076)
# Related Disease Score Top Affiliating Genes
1 ischemic fasciitis 34.6 USP6 ACTC1
2 proliferative fasciitis 34.4 USP6 MYH9
3 intravascular fasciitis 34.2 USP6 MYH9 ESR1 CD34
4 necrotizing fasciitis 34.2 LTA IL6 IL2 IL1RN IL18 CXCL8
5 pseudosarcomatous fibromatosis 33.6 VIM USP6 MYH9 CD34 ACTC1
6 toxic shock syndrome 32.4 TNF LTA IL6 IL2 IL1RN IFNG
7 cellulitis 31.7 TNF IL6 IL2 IFNG
8 hypereosinophilic syndrome 31.6 IL2 IFNG IFNA1 CXCL8
9 localized scleroderma 31.4 TNF IL6 IL2 CD34
10 myositis 31.3 TNF IL6 IFNG IFNA1 CXCL8
11 pyoderma 31.2 TNF IL1RN CXCL8
12 pyoderma gangrenosum 31.2 TNF IL1RN CXCL8
13 soft tissue sarcoma 31.1 TP53 TNF IFNG
14 spindle cell sarcoma 31.1 VIM CD34 ACTC1
15 erysipelas 31.1 TNF IL6 IL2 IL1RN
16 streptococcal toxic-shock syndrome 31.0 TNF LTA IL6 IL2 CXCL8
17 tenosynovitis 30.9 TNF IL6 IL1RN
18 appendicitis 30.9 TNF IL6 IL2 IFNG CXCL8
19 chickenpox 30.9 TNF IL6 IL2 IFNG IFNA1 ACTC1
20 peritonitis 30.9 TNF IL6 IL18 IFNG CXCL8
21 graft-versus-host disease 30.8 TNF IL6 IL2 IFNG
22 septic arthritis 30.8 TNF IL6 IFNG CXCL8
23 pyelonephritis 30.8 TNF IL6 IFNG CXCL8
24 mixed connective tissue disease 30.8 TNF IL6 IFNG
25 haemophilus influenzae 30.8 TNF CXCL8
26 osteomyelitis 30.8 TNF IL6 IL1RN IFNG CXCL8
27 purpura 30.7 TNF IL6 IFNG
28 fibrous histiocytoma 30.7 VIM TP53 CD34 ACTC1
29 histiocytosis 30.7 TNF IL1RN IFNG
30 carpal tunnel syndrome 30.7 IL6 IL2 IL1RN ESR1
31 synovitis 30.7 TNF IL6 IL1RN IL18 CXCL8
32 perinatal necrotizing enterocolitis 30.7 TNF IL6 CXCL8
33 thyroiditis 30.7 TNF IL6 IL2 IFNA1
34 pustulosis of palm and sole 30.7 TNF IL1RN CXCL8
35 pharyngitis 30.6 TNF IL6 IL1RN CXCL8
36 cutaneous fibrous histiocytoma 30.6 VIM CD34 ACTC1
37 gout 30.6 TNF IL6 IL18 CXCL8
38 lyme disease 30.6 TNF IL6 IL18 IFNA1
39 herpes zoster 30.6 TNF IL2 IFNG IFNA1
40 end stage renal disease 30.6 TNF MYH9 IL6 IL1RN CD46
41 fibrosarcoma 30.5 VIM TP53 TNF ETV6 ACTC1
42 respiratory failure 30.5 TNF LTA IL6 IL1RN CXCL8
43 endocarditis 30.5 TNF IL6 IFNG CXCL8
44 dermatofibrosarcoma protuberans 30.5 VIM TP53 CD34 ACTC1
45 melioidosis 30.5 TNF IL6 IL18 IFNG
46 varicose veins 30.5 TNF IL6 ESR1 CXCL8
47 bacterial infectious disease 30.5 TNF IL6 IL1RN IL18 IFNG CXCL8
48 pericarditis 30.5 TNF IL6 IL1RN IFNG CXCL8
49 pericardial effusion 30.5 IL6 IL1RN CD34
50 sarcoma 30.4 VIM TP53 IL6 IFNA1 CXCL8 ACTC1

Graphical network of the top 20 diseases related to Fasciitis:



Diseases related to Fasciitis

Symptoms & Phenotypes for Fasciitis

MGI Mouse Phenotypes related to Fasciitis:

45 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.4 ACTC1 CD46 ESR1 ETV6 IFNG IL18
2 cellular MP:0005384 10.36 ACTC1 CD34 ESR1 ETV6 IFNG IL18
3 homeostasis/metabolism MP:0005376 10.33 ACTC1 CD34 ESR1 ETV6 IFNG IL18
4 hematopoietic system MP:0005397 10.32 CD34 ESR1 ETV6 IFNG IL18 IL1RN
5 immune system MP:0005387 10.25 CD34 ESR1 ETV6 IFNG IL18 IL1RN
6 digestive/alimentary MP:0005381 10.1 ESR1 ETV6 IFNG IL18 IL2 IL6
7 integument MP:0010771 10.06 CD34 ESR1 ETV6 IFNG IL18 IL1RN
8 muscle MP:0005369 9.97 ACTC1 ESR1 IFNG IL18 IL6 TNF
9 neoplasm MP:0002006 9.92 CD34 ESR1 ETV6 IFNG IL2 IL6
10 no phenotypic analysis MP:0003012 9.86 ESR1 ETV6 IFNG IL2 MYH9 TNF
11 reproductive system MP:0005389 9.85 CD46 ESR1 IFNG IL1RN IL2 IL6
12 respiratory system MP:0005388 9.56 ESR1 IFNG IL2 IL6 LTA TNF
13 vision/eye MP:0005391 9.32 CD46 IFNG IL18 IL2 IL6 LTA

Drugs & Therapeutics for Fasciitis

Drugs for Fasciitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 130)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
2
Imidacloprid Vet_approved Phase 4 105827-78-9 86418
3 Cholinergic Agents Phase 4
4 incobotulinumtoxinA Phase 4
5 Gastrointestinal Agents Phase 4
6 Antineoplastic Agents, Hormonal Phase 4
7 Neuroprotective Agents Phase 4
8 Antiemetics Phase 4
9 Protective Agents Phase 4
10
rituximab Approved Phase 2 174722-31-7 10201696
11
Polidocanol Approved Phase 2 9002-92-0
12 Antirheumatic Agents Phase 2
13 Antineoplastic Agents, Immunological Phase 2
14 Immunologic Factors Phase 2
15 Antibodies Phase 2
16 Rho(D) Immune Globulin Phase 2
17 Immunoglobulins, Intravenous Phase 2
18 gamma-Globulins Phase 2
19 Immunoglobulin G Phase 2
20 Immunoglobulins Phase 2
21 Pharmaceutical Solutions Phase 2
22 Sclerosing Solutions Phase 2
23 abobotulinumtoxinA Phase 2
24 Botulinum Toxins, Type A Phase 2
25
Acetylcholine Approved, Investigational Phase 1 51-84-3 187
26
Ropivacaine Approved Phase 1 84057-95-4 71273 175805
27
Carbon monoxide Approved, Investigational Phase 1 630-08-0 281
28 Neurotransmitter Agents Phase 1
29 Botulinum Toxins Phase 1
30 Betamethasone acetate phosphate Phase 1
31 Adrenergic beta-Agonists Phase 1
32 Adrenergic Agents Phase 1
33 Adrenergic Agonists Phase 1
34 Vaccines Phase 1
35 Adrenergic Antagonists Phase 1
36 Adrenergic beta-Antagonists Phase 1
37 Bromoacetylalprenololmenthane Phase 1
38
Celecoxib Approved, Investigational 169590-42-5 2662
39
Acetaminophen Approved 103-90-2 1983
40
leucovorin Approved 58-05-9 6006 143
41
Methotrexate Approved 59-05-2, 1959-05-2 126941
42
Daptomycin Approved, Investigational 103060-53-3 16129629
43
Protein C Approved
44
Sulfamethazine Approved, Investigational, Vet_approved 57-68-1 5327
45
Doxycycline Approved, Investigational, Vet_approved 564-25-0 54671203
46
Sulfamethoxazole Approved 723-46-6 5329
47
Trimethoprim Approved, Vet_approved 738-70-5 5578
48
Bupivacaine Approved, Investigational 2180-92-9, 38396-39-3 2474
49
Methylprednisolone Approved, Vet_approved 83-43-2 6741
50
Methylprednisolone hemisuccinate Approved 2921-57-5

Interventional clinical trials:

(show top 50) (show all 186)
# Name Status NCT ID Phase Drugs
1 A Post-marketing Surveillance to Evaluate the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis Unknown status NCT02539082 Phase 4 normal saline
2 Plantar Fasciitis: Pain Relief and Improvement of Foot Function With Prolotherapy Unknown status NCT01326351 Phase 4
3 Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study. Unknown status NCT01509274 Phase 4
4 Negative Pressure Wound Therapy With the Engenex™-Pump and Bio-Dome™ Dressing, an Evaluation Unknown status NCT01107821 Phase 4
5 Treatment of Plantar Fasciitis With Xeomin: A Randomized, Placebo-Controlled, Double-Blinded, Prospective Study Completed NCT01678001 Phase 4 Xeomin
6 Conservative Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports: a Prospective Randomized Study Completed NCT00222911 Phase 4
7 Chronic Plantar Fasciitis Treated With Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes? A Randomized Controlled Clinical Trial. Completed NCT02608723 Phase 4
8 Use of PRP to Treat Plantar Fasciitis, Blinded and Randomized as a Multi Center Study Completed NCT00758641 Phase 4 Corticosteroid Injection
9 Optimal Treatment of Plantar Fasciitis: A Randomized Clinical Trial Using Physical Training, Glucocorticoid Injections or a Combination Thereof. Completed NCT01994759 Phase 4 Glucocorticosteroid injection
10 Randomized Clinical Trial Comparing Conventional Conservative Treatment for Plantar Fasciopathia With Endoscopic Surgery With Fascial Release. Completed NCT02448316 Phase 4 methylprednisolon;lidokaine
11 Shockwave Therapy of Chronic Achilles Tendinopathy. A Double-blind, Randomized Clinical Trial of Efficacy Completed NCT00958620 Phase 4
12 Plantar Fasciosis Treatment Using Coblation® Prospective, Double-Blind, Randomized Controlled Study Completed NCT00189592 Phase 4
13 Clinical Effectiveness of Quiropodiatry and Orthesis on Heel and Plantar Pain: Randomized Control Trial Completed NCT00888394 Phase 4
14 A Prospective, Double-Blinded, Randomized Controlled Trial of Dehydrated Human Amniotic-Chorionic Membrane for Incisional Hernia Prophylaxis Recruiting NCT04417140 Phase 4
15 Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy Terminated NCT01588730 Phase 4
16 "Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis" Withdrawn NCT00420875 Phase 4
17 PSU Heel Cushion for Treatment of Plantar Fasciitis:A Randomized Controlled Trial Unknown status NCT01017406 Phase 3
18 The Effect of Extracorporeal Shock Wave Therapy (ESWT)of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Unknown status NCT01786057 Phase 2, Phase 3
19 Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport®) in the Treatment of Chronic Plantar Fasciitis Completed NCT00447876 Phase 2, Phase 3 Placebo
20 A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis Completed NCT02427191 Phase 2, Phase 3 Saline Injection
21 Placebo Controlled Study to Investigate the Effectiveness and Safety of Extracorporeal Shock Wave Therapy in Unsuccessful Conservatively Treated Subject Suffering From Painful Heel Syndrome Completed NCT00720694 Phase 3
22 Continuous Low Energy Pulsed Radio Frequency Electromagnetic Field Therapy for the Treatment of Plantar Fasciopathy Completed NCT01431066 Phase 3
23 Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections) Completed NCT02469857 Phase 3 AB103 0.5 mg/kg
24 A Clinical Trial of a Multi-Element Exercise Program for Plantar Fasciopathy in Workers Required to Stand for Prolonged Periods of Time Completed NCT01297686 Phase 2, Phase 3 Dexamethasone
25 Use of the dermaPACE™ (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care in the Treatment of Diabetic Foot Ulcers Completed NCT00536744 Phase 3
26 A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Plantar Fasciitis Recruiting NCT03414268 Phase 3 Saline Injection
27 Steroid Injections vs. Platelet Rich Plasma Injections in Patients With Plantar Fasciitis: A Comparison of Clinical and Ultrasound Findings Withdrawn NCT01957631 Phase 2, Phase 3 Corticosteroid injection (Bupivacaine and Depo Medrol)
28 A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy Unknown status NCT00936546 Phase 2 Rituximab
29 DermaGold Indicated for Use of Shockwave Treat of Diabetic Foot Ulcers in Patients With Diabetes Mellitus Unknown status NCT00366132 Phase 2
30 A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Completed NCT03137407 Phase 2
31 Treatment of Osteoporosis With Unfocused Extracorporeal Shock Wave Therapy: Pilot Study Completed NCT02630381 Phase 2
32 Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial Completed NCT02111161 Phase 2 IVIG (Privigen);Saline 0.9%
33 A Single-Arm, Open-Label, Phase I/II Study of Glasdegib for Sclerotic Chronic Graft-Vs-Host Disease Recruiting NCT04111497 Phase 1, Phase 2 Glasdegib
34 A Single Arm, Open Label, Phase II Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids Recruiting NCT03616184 Phase 2 Ruxolitinib
35 Phase II Trial on the Efficacy and Safety of Sclerotherapy Using 3% Polidocanol Foam to Treat Second-degree Hemorrhoidal Disease Recruiting NCT03791775 Phase 2 Polidocanol foam (Atossisclerol® 3%)
36 A Phase II, Prospective, Randomized, Double-Blind, Multi-center, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Active, not recruiting NCT03825315 Phase 2
37 A Phase II Clinical Trial Evaluating the Safety and Effect of abobotulinumtoxinA Injection in the Gastrocnemius Muscle to Improve Equinus and Associated Plantar Fasciitis Pain Not yet recruiting NCT03978234 Phase 2 AbobotulinumtoxinA 300 UNT
38 A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Terminated NCT02973269 Phase 2
39 Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis. Completed NCT03054610 Phase 1 Betamethason Sodium Phosphate;Ropivacaine;Botulinum Toxins, Type A
40 Group A Streptococcal Human Challenge Study: Building a Pharyngitis Model to Accelerate Vaccine Development Completed NCT03361163 Phase 1
41 A Prospective, Non-Randomized, Open-Label Study on the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children Completed NCT00670891 Phase 1
42 Mepolizumab for the Treatment of Eosinophilic Fasciitis; An Open-Label, Single-Arm, Exploration Study Not yet recruiting NCT04305678 Phase 1 Mepolizumab
43 Shulman Fasciitis Prevalence Study in Alsace Unknown status NCT02829112
44 Effect of Plantar Fasciitis Foot Insole Unknown status NCT01549678
45 Factors Associated With Complications of Cervical Necrotizing Fasciitis Unknown status NCT02847234
46 A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy With Platelet Rich Plasma Versus Extracorporeal Shock Wave Therapy in a High Demand Cohort With Resistant Plantar Fasciitis Unknown status NCT02668510 Normal saline
47 The Investigation of Biomechanical Mechanism of Different Foot Structures on Plantar Fasciitis and the Evaluation of Efficacy on Therapeutic Footwear Unknown status NCT01363375
48 Sonoelastographic Changes After Low Energy Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis Unknown status NCT01981226
49 Integrated 3D Surface Scanning System Combined With Soft Tissue and Skeleton Information: Customized Shoe-padding Orthotics for Plantar Fasciitis Unknown status NCT03226288
50 A Randomized Double-Blind Clinical Trial to Investigate the Use of Autologous Conditioned Plasma (ACP) for Patients With Plantar Fasciitis Unknown status NCT01614223 Corticosteroid (celestone) injection

Search NIH Clinical Center for Fasciitis

Cochrane evidence based reviews: fasciitis

Genetic Tests for Fasciitis

Anatomical Context for Fasciitis

The Foundational Model of Anatomy Ontology organs/tissues related to Fasciitis:

19
Fascia

MalaCards organs/tissues related to Fasciitis:

40
Skin, Breast, Bone, Thyroid, Colon, Liver, Testes

Publications for Fasciitis

Articles related to Fasciitis:

(show top 50) (show all 7635)
# Title Authors PMID Year
1
Cranial fasciitis of childhood: a case report and review of literature. 61 54
18190448 2008
2
Cranial and extracranial fasciitis of childhood: a clinicopathologic and immunohistochemical study. 61 54
9923933 1999
3
Therapeutic efficacy of platelet-rich plasma injection compared to corticosteroid injection in plantar fasciitis: A systematic review and meta-analysis. 61
32336895 2020
4
Necrotising fasciitis in a ten month old infant. 61
32489886 2020
5
Nodular Fasciitis Mimicking Pleomorphic Adenoma. 61
31064246 2020
6
The biofilm-associated bacterial infections unrelated to indwelling devices. 61
32150327 2020
7
Incidence and treatment costs of severe bacterial infections among people who inject heroin: A cohort study in South London, England. 61
32422537 2020
8
Evolutionary anatomy of the plantar aponeurosis in primates, including humans. 61
32103502 2020
9
Crystal Structure of Exotoxin A from Aeromonas Pathogenic Species. 61
32549399 2020
10
Non-irradiated GCSF stimulated leukocyte transfusion for necrotizing fasciitis after allogeneic stem cell transplant: a case report and review of the literature. 61
31700136 2020
11
Spontaneous closure of an extensive postdebridement perineal wound in a newly diagnosed diabetic patient presenting with necrotizing fasciitis. 61
32577261 2020
12
Combined Timed Surgery and Conservative Management of Primary Necrotizing Fasciitis of the Breast: A Case Report. 61
32487979 2020
13
Delay in the Referral of Pregnant Patients with Fascial Spaces Infection: A Cross-Sectional Observational Study from Khartoum Teaching Dental Hospital, Sudan. 61
32346243 2020
14
Mucormycosis due to Apophysomyces species complex- 25 years' experience at a tertiary care hospital in southern India. 61
31342074 2020
15
An outbreak of acute skin and soft tissue infections including necrotizing fasciitis in Kalwala village, India, 2018: Public health implications for the lymphatic filariasis elimination program. 61
32562418 2020
16
[The 478 th case: multiple myalgia with intramuscular nodules]. 61
32486593 2020
17
Injection Techniques for Common Chronic Pain Conditions of the Foot: A Comprehensive Review. 61
32107725 2020
18
Eosinophilic Fasciitis in a Patient With Crohn's Disease Treated With Infliximab. A Rare Coexistence or a Drug-related Manifestation? 61
32529216 2020
19
First application of focused low-energy extracorporeal shockwave therapy in a patient with severe hemophilia A and plantar fasciitis. 61
32533438 2020
20
Delayed presentation of breast necrotising fasciitis due to COVID-19 anxiety. 61
32536015 2020
21
Upper extremity exertional rhabdomyolysis: MR imaging findings in four cases. 61
32346455 2020
22
Near-fatal poisoning after ricin injection. 61
32475181 2020
23
[Limb necrotizing soft tissue infection (NSTI) and necrotising fasciitis: A bicentric study between 2000 and 2017 on the quality of life and functional impact]. 61
31186207 2020
24
The effect of high-intensity versus low-level laser therapy in the management of plantar fasciitis: randomized participant blind controlled trial. 61
32513018 2020
25
Necrotizing Fasciitis Following Routine Genitourinary Surgery In Healthy Infants. 61
32531466 2020
26
Candida albicans necrotizing fasciitis following elective surgery. 61
32420013 2020
27
Management and Treatment of Necrotizing Fasciitis. 61
32525996 2020
28
Necrotizing Fasciitis Complicating Transobturator Tape Operation. 61
32526742 2020
29
Independent Predictors of Mortality for Aeromonas Necrotizing Fasciitis of Limbs: An 18-year Retrospective Study. 61
32382057 2020
30
Severe bacterial skin infections. 61
32507327 2020
31
Predictors of fatal outcome after severe necrotizing fasciitis: Retrospective analysis in a tertiary hospital for 20 years. 61
32414564 2020
32
Nodular fasciitis of the breast. 61
32052513 2020
33
Recurrent and novel USP6 fusions in cranial fasciitis identified by targeted RNA sequencing. 61
31827231 2020
34
An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging finding. 61
32344435 2020
35
Eosinophilic fasciitis associated with generalized morphea and IgA nephropathy. 61
32441406 2020
36
Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled retrospective study of 101 patients. 61
32007650 2020
37
The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review. 61
31974818 2020
38
Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis. 61
31820721 2020
39
Necrotizing fasciitis in haematological patients: a different scenario. 61
32399706 2020
40
A 16-year Longitudinal Cohort Study of Incidence and Bacteriology of Necrotising Fasciitis in England. 61
32383053 2020
41
Eosinophilic Dermatoses: Recognition and Management. 61
32394361 2020
42
Herpes zoster infection-induced common peroneal nerve paresis resulting in foot drop in a patient with eosinophilic fasciitis: a case report. 61
32075466 2020
43
Lactoferrin: A Critical Mediator of Both Host Immune Response and Antimicrobial Activity in Response to Streptococcal Infections. 61
32329605 2020
44
Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace. 61
32384624 2020
45
Nuclear Medicine for the Orthopedic Foot and Ankle Surgeon. 61
32141327 2020
46
Finegoldia magna: a rare cause of necrotising fasciitis. 61
32467123 2020
47
Well-Differentiated/Dedifferentiated Liposarcoma Arising in the Upper Aerodigestive Tract: 8 Cases Mimicking Non-adipocytic Lesions. 61
32410132 2020
48
Platelet-Rich Plasma Versus Corticosteroids in the Treatment of Chronic Plantar Fasciitis: A Systematic Review and Meta-analysis of Prospective Comparative Studies. 61
32354511 2020
49
Correction to: Novel CTNNB1-USP6 fusion in intravascular fasciitis of the large vein identified by next-generation sequencing. 61
32472194 2020
50
Plantar pressure distribution and spatiotemporal gait parameters after the radial shock wave therapy in patients with chronic plantar fasciitis. 61
32279933 2020

Variations for Fasciitis

Expression for Fasciitis

Search GEO for disease gene expression data for Fasciitis.

Pathways for Fasciitis

Pathways related to Fasciitis according to GeneCards Suite gene sharing:

(show top 50) (show all 66)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.05 VIM TP53 TNF MYH9 LTA IL6
2
Show member pathways
13.87 VIM TP53 TNF MYH9 LTA IL6
3
Show member pathways
13.73 TP53 TNF LTA IL6 IL2 IL1RN
4
Show member pathways
13.59 TP53 TNF LTA IL6 IL2 IL18
5
Show member pathways
13.34 TNF MYH9 LTA IL6 IL2 IL18
6
Show member pathways
13.33 VIM TP53 TNF LTA IL6 IL2
7
Show member pathways
13.1 TP53 TNF IL6 IL2 IFNG IFNA1
8 12.89 TP53 IL6 IL2 IFNG IFNA1 ESR1
9 12.86 TP53 TNF LTA IL6 IFNG IFNA1
10
Show member pathways
12.85 VIM TNF LTA IL6 IL2 IFNG
11
Show member pathways
12.78 TNF IL6 IL1RN IL18 IFNA1 CXCL8
12
Show member pathways
12.64 VIM TNF IL6 IL2 IFNG
13
Show member pathways
12.64 TNF IL6 IL2 IL18 IFNG
14
Show member pathways
12.64 TP53 TNF IL6 IL2 IL18 IFNG
15 12.59 TNF IL2 IL1RN IFNG IFNA1 CD46
16 12.42 TP53 TNF IL18 CXCL8
17 12.4 TP53 TNF LTA IL6 IL2
18
Show member pathways
12.4 TNF LTA IL6 IL2 IL18 CXCL8
19
Show member pathways
12.39 TP53 TNF IL6 IL2 IFNG
20
Show member pathways
12.38 TP53 TNF IL6 IFNG CXCL8
21
Show member pathways
12.37 TNF IL6 IFNG CXCL8
22 12.37 TNF MYH9 IL6 IL18 CXCL8
23 12.33 TNF MYH9 IL6 IL18 CXCL8
24 12.31 TP53 IL6 ETV6 CXCL8
25 12.3 TNF IL6 IL18 IFNA1 CXCL8
26 12.29 TNF IL6 IL18 IFNG IFNA1
27 12.24 TP53 TNF IL6 IFNG
28
Show member pathways
12.23 TNF IL6 IFNG CXCL8
29 12.22 TNF IL6 IL1RN CXCL8
30 12.08 TNF IL6 IL2 IL18 CXCL8
31 12.06 TNF IL6 IL2 IFNG CD34
32
Show member pathways
12.03 VIM TP53 TNF IL6 IL2 IL18
33 12.01 TP53 IL6 IFNG CXCL8
34 11.99 TNF IL6 IFNG CXCL8
35 11.93 TNF IL6 IL18 IFNG CXCL8
36 11.9 VIM TP53 TNF IL6 IL18 CXCL8
37 11.86 TP53 IL6 IL2 IFNG CXCL8
38
Show member pathways
11.83 TNF IL2 IFNG CXCL8
39
Show member pathways
11.82 TNF LTA IL6 IL2 IL18 IFNG
40
Show member pathways
11.82 TP53 TNF LTA IL6 IL2 IL18
41 11.79 TNF IL6 CXCL8
42 11.79 TNF IL6 IL2 IFNG CD34
43 11.78 VIM TP53 TNF IL6 IL2 IFNG
44 11.73 IL2 IFNG ESR1
45 11.7 TNF IL6 CXCL8
46
Show member pathways
11.69 TNF IL2 IFNG
47
Show member pathways
11.69 TNF IL6 IL2 IFNG CXCL8
48 11.68 TNF IL6 IL18 CXCL8
49 11.64 IL6 IFNG CXCL8
50 11.64 TNF LTA IL2 IL18 IFNG CD34

GO Terms for Fasciitis

Cellular components related to Fasciitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.65 TNF LTA IL6 IL2 IL1RN IL18
2 extracellular space GO:0005615 9.32 TNF LTA IL6 IL2 IL1RN IL18

Biological processes related to Fasciitis according to GeneCards Suite gene sharing:

(show all 30)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription by RNA polymerase II GO:0045944 10.16 TP53 TNF IL6 IL2 IL18 ETV6
2 inflammatory response GO:0006954 9.98 TNF IL6 IL1RN IL18 CXCL8
3 negative regulation of gene expression GO:0010629 9.91 TP53 TNF IFNG ESR1 CD46 CD34
4 cellular response to lipopolysaccharide GO:0071222 9.88 VIM TNF IL6 CXCL8
5 immune response GO:0006955 9.86 TNF LTA IL6 IL2 IL1RN IL18
6 response to glucocorticoid GO:0051384 9.8 TNF IL6 IL1RN
7 positive regulation of inflammatory response GO:0050729 9.8 TNF IL2 IL18 IFNG
8 positive regulation of T cell proliferation GO:0042102 9.78 IL6 IL2 CD46
9 positive regulation of smooth muscle cell proliferation GO:0048661 9.77 TNF IL6 IL18
10 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.72 TNF IL6 IL2 IL18 IFNG
11 positive regulation of interferon-gamma production GO:0032729 9.67 TNF LTA IL2 IL18
12 negative regulation of amyloid-beta clearance GO:1900222 9.65 TNF IFNG
13 positive regulation of glial cell proliferation GO:0060252 9.65 TNF LTA IL6
14 negative regulation of lipid storage GO:0010888 9.64 TNF IL6
15 response to salt stress GO:0009651 9.64 TP53 TNF
16 positive regulation of transforming growth factor beta production GO:0071636 9.63 CD46 CD34
17 positive regulation of interleukin-1 beta biosynthetic process GO:0050725 9.63 TNF IFNG
18 positive regulation of neuroinflammatory response GO:0150078 9.63 TNF IL6 IL18
19 circadian behavior GO:0048512 9.61 USP2 TP53
20 positive regulation of gene expression GO:0010628 9.61 VIM TP53 TNF IL6 IL18 IFNG
21 negative regulation of interleukin-1-mediated signaling pathway GO:2000660 9.59 IL6 IL1RN
22 negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799 9.58 TP53 TNF ESR1
23 positive regulation of tissue remodeling GO:0034105 9.57 IL2 IL18
24 positive regulation of humoral immune response mediated by circulating immunoglobulin GO:0002925 9.56 TNF LTA
25 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.55 TNF IFNG
26 humoral immune response GO:0006959 9.55 TNF LTA IL6 IFNG IFNA1
27 positive regulation of vitamin D biosynthetic process GO:0060557 9.54 TNF IFNG
28 positive regulation of nitrogen compound metabolic process GO:0051173 9.52 TNF IFNG
29 positive regulation of chronic inflammatory response to antigenic stimulus GO:0002876 9.51 TNF LTA
30 cytokine-mediated signaling pathway GO:0019221 9.28 VIM TP53 TNF IL6 IL2 IL1RN

Molecular functions related to Fasciitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.28 TNF LTA IL6 IL2 IL1RN IL18

Sources for Fasciitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....